Intellia Therapeutics (NTLA) Times Interest Earned (2015 - 2026)
Intellia Therapeutics' (NTLA) quarterly Times Interest Earned came in at -$1.04 in Q1 2026, down 22.65% year-on-year from -$1.34 in Q1 2025, and up 99.95% on a QoQ basis from -$1974.2 in Q4 2025.
Intellia Therapeutics (NTLA) Times Interest Earned (2015 - 2026) Analysis & Trends
Intellia Therapeutics (NTLA) has 12 years of Times Interest Earned data on file, last reported at -$1.04 in Q1 2026.
- On a quarterly basis, Times Interest Earned fell 22.65% year-over-year to -$1.04 in Q1 2026; TTM through Mar 2026 was -$4.34, a 14.6% decrease from a year earlier, with the FY2025 full-year figure at -$0.48, up 29.32% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$1.04, up from -$1974.2 in the prior quarter.
- Over the last five years, Times Interest Earned for NTLA reached as high as -$0.7 in Q1 2022 and fell as low as -$1974.2 in Q4 2025.
- Historically, Times Interest Earned has averaged -$132.55 across 5 years, with a median of -$3.29 in 2023.
- Across the five-year window, Times Interest Earned slumped 5067.76% in 2024 and soared 92.64% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$28.8 in 2022, then surged by 86.48% to -$3.89 in 2023, then slumped by 5067.76% to -$201.25 in 2024, then slumped by 880.97% to -$1974.2 in 2025, then surged by 99.95% to -$1.04 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$1.04 in Q1 2026, -$1974.2 in Q4 2025, and -$0.95 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Intellia Therapeutics | 1.32 Bn | 1.32 Bn | - | -1.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.04 |
| Dec 31, 2025 | -1,974.20 |
| Sep 30, 2025 | -0.95 |
| Jun 30, 2025 | -7.03 |
| Mar 31, 2025 | -0.85 |
| Dec 31, 2024 | -201.25 |
| Sep 30, 2024 | -12.87 |
| Jun 30, 2024 | -8.79 |
| Mar 31, 2024 | -4.13 |
| Dec 31, 2023 | -3.89 |
| Sep 30, 2023 | -3.29 |
| Jun 30, 2023 | -1.93 |
| Mar 31, 2023 | -1.89 |
| Dec 31, 2022 | -28.80 |
| Sep 30, 2022 | -0.90 |
| Jun 30, 2022 | -0.93 |
| Mar 31, 2022 | -0.70 |
| Dec 31, 2021 | -37.84 |
| Sep 30, 2021 | -0.12 |
| Jun 30, 2021 | -0.07 |